Drug stocks are the opportunity of the decade, says Neil Woodford
The pharmaceutical industry represents a 'once-in-a-decade' opportunity for investors, says Invesco's Neil Woodford.
Invesco Perpetual fund manager Neil Woodford reckons that the pharmaceutical industry represents a once-in-a-decade opportunity. Woodford, one of the UK's best-known fund managers, tells Money Marketing magazine that the drug sector is "being given away by the stockmarket".
Woodford targets high-yielding sectors, such as utilities, for his income-driven investment funds and is known for his outspoken views on how these sectors are run and regulated. This time, however, his ire is directed towards fellow investors.
He feels they are underestimating the impact of "big pharma's" massive investment in research and development. Highlighting AstraZeneca he said: "Analysts are assuming [the company] will spend $50bn in 10 years on the pipeline and get nothing back."
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Woodford has already invested around 25% of the £17bn he manages into the sector and says he "has never seen valuations like this". Indeed, he reckons pharma is as attractive as another of his other favoured sectors tobacco was "25 years ago", since when the sector has delivered total shareholder returns of more than 9,000%.
But investors should move fast. "Pharmaceuticals is a very strong and powerful industry I do not think the market will ignore valuations for very much longer."
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
James graduated from Keele University with a BA (Hons) in English literature and history, and has a certificate in journalism from the NCTJ. James has worked as a freelance journalist in various Latin American countries.He also had a spell at ITV, as welll as wring for Television Business International and covering the European equity markets for the Forbes.com London bureau. James has travelled extensively in emerging markets, reporting for international energy magazines such as Oil and Gas Investor, and institutional publications such as the Commonwealth Business Environment Report. He is currently the managing editor of LatAm INVESTOR, the UK's only Latin American finance magazine.
-
8 of the best properties for sale with smallholdings
Eight of the best properties for sale with smallholdings – from a 17th-century farmhouse in the Deben Valley, Suffolk, to a property set in 36 acres on the slopes of the Preseli Hills, Pembrokeshire
By Natasha Langan Published
-
US election – is the Trump Trade back?
The US election is around the corner. How does Trump influence US markets?
By Alex Rankine Published